Literature DB >> 11912940

Liver transplantation in patients with alcohol and other substance use disorders.

Andrea DiMartini1, Robert Weinrieb, Marian Fireman.   

Abstract

It is unfortunate that LT is not the ultimate sobering experience. LT patients can and do relapse; however, relapse to alcohol or substance use should no more be considered a failure of LT than the recurrence of HCV after LT. It is a phenomenon of their addiction. As a group, the survival and outcomes of patients undergoing LT for ALD are not significantly different from those undergoing LT for other causes. The fact that few patients return to heavy and deleterious alcohol or substance use attests to the success of programs in selecting patients capable of caring for themselves and their livers after LT. In the pre-LT phase, establishing the correct addiction diagnosis is essential so that those at highest risk can be carefully monitored. Although information is emerging about other risk factors for relapse, the authors caution against considering patients with these characteristics as being categorically unfit for LT. Each individual is unique, and such factors should guide clinical decision making rather than being absolute contraindications. After LT, clinical interviews, preferably by a trained psychiatric physician or clinician, are essential to monitoring alcohol and substance use, and surveillance early on is required. Much work needs to be done with respect to substance use and relapse after LT because few studies have explored these issues. In addition, the special treatment needs of those who relapse has not been addressed. Treatment research is underway but has relied on traditional strategies that are not always applicable to LT recipients. Further areas to improve clinical care include improving health behaviors, specifically, smoking cessation. The authors anticipate that, in the near future, the ongoing work in this area will provide information and guidance to physicians and clinicians caring for these unique patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11912940     DOI: 10.1016/s0193-953x(03)00058-3

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  8 in total

1.  Meta-analysis of risk for relapse to substance use after transplantation of the liver or other solid organs.

Authors:  Mary Amanda Dew; Andrea F DiMartini; Jennifer Steel; Annette De Vito Dabbs; Larissa Myaskovsky; Mark Unruh; Joel Greenhouse
Journal:  Liver Transpl       Date:  2008-02       Impact factor: 5.799

2.  Physical health and drinking among medical inpatients with unhealthy alcohol use: a prospective study.

Authors:  Emily C Williams; Tibor Palfai; Debbie M Cheng; Jeffrey H Samet; Katharine A Bradley; Thomas D Koepsell; Thomas M Wickizer; Patrick J Heagerty; Richard Saitz
Journal:  Alcohol Clin Exp Res       Date:  2010-05-04       Impact factor: 3.455

Review 3.  Calcineurin signaling as a target for the treatment of alcohol abuse and neuroinflammatory disorders.

Authors:  Patrick J Ronan; Sarah A Flynn; Thomas P Beresford
Journal:  Prog Mol Biol Transl Sci       Date:  2019-08-12       Impact factor: 3.622

4.  Liver transplant recipients: individual, social, and environmental resources.

Authors:  Carol S Stilley; Andrea F DiMartini; Ralph E Tarter; Michael DeVera; Susan Sereika; Mary Amanda Dew; Jennifer King; William B Flynn
Journal:  Prog Transplant       Date:  2010-03       Impact factor: 1.065

Review 5.  Organ transplant & the psychiatrist: An overview.

Authors:  B N Anil Kumar; Surendra Kumar Mattoo
Journal:  Indian J Med Res       Date:  2015-04       Impact factor: 2.375

6.  Reluctance to Accept Alcohol Treatment by Alcoholic Liver Disease Transplant Patients: A Qualitative Study.

Authors:  Cathy M Heyes; Toni Schofield; Robert Gribble; Carolyn A Day; Paul S Haber
Journal:  Transplant Direct       Date:  2016-09-07

7.  Successful lung transplantation for talcosis secondary to intravenous abuse of oral drug.

Authors:  Dekel Shlomi; David Shitrit; Daniele Bendayan; Gidon Sahar; Yitshak Shechtman; Mordechai R Kramer
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

8.  Effects of Tacrolimus and Other Immune Targeting Compounds on Binge-Like Ethanol Drinking in High Drinking in the Dark Mice.

Authors:  Kolter B Grigsby; Antonia M Savarese; Pamela Metten; Barbara J Mason; Yuri A Blednov; John C Crabbe; Angela R Ozburn
Journal:  Neurosci Insights       Date:  2020-11-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.